Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Katalin Karikó, Michael Buckstein, Houping Ni et al. · Immunity · 2005 · 2.6K citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Katalin Karikó, Hiromi Muramatsu, Frank A. Welsh et al. · Molecular Therapy · 2008 · 1.9K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu et al. · Journal of Controlled Release · 2015 · 1K citations

Pharmacy, Molecular Biology, Molecular Pharmaceutics +17

Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

Kevin Kauffman, J. Robert Dorkin, Jung Hoon Yang et al. · Nano Letters · 2015 · 768 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Nonviral delivery of self-amplifying RNA vaccines

Andrew J. Geall, Ayush Verma, Gillis R. Otten et al. · Proceedings of the National Academy of Sciences · 2012 · 667 citations · Full text

Life Sciences, Biotechnology, Immunology +17